
Kevin Ketcham
Articles
-
2 months ago |
ionanalytics.com | Reuben Jonathan Miller |Kevin Ketcham |Kevin McCaffrey |Carlos Martinez
News (Intelligence) Foreign regulatory reviews of US-backed deals may emerge as easy targets for retaliationAmong neighbors and longtime trade adversary, China represents most acute threatPending deals such as Ansys/Synopsys represent potential bellwethersThe world knew that US President Donald Trump planned to use tariffs as an economic cudgel and businesspeople worldwide have been abuzz discussing the matter for months.
-
Nov 6, 2024 |
ionanalytics.com | Kevin Ketcham |Kevin McCaffrey |Carlos Martinez
Data Insight Our analysts pick out hints of future material developments in M&A and ECM situations to produce an exclusive report that offers short and long-term actionable ideas (no investment action should be taken without further investigation). If you have any ideas for coverage, please email .
Deal Focus: Tailwater Capital to take Summit Midstream stake post-Tall Oak Midstream III transaction
Nov 1, 2024 |
ionanalytics.com | Serafina Smith |Kevin Ketcham |Carlos Martinez
News (Intelligence) Tailwater Capital began looking at options for portfolio company Tall Oak Midstream III (Tall Oak) about eighteen months ago, including a potential exit strategy for 2024. “The business has performed well over the last couple of years” said Stephen Lipscomb, a partner at the Dallas-based sponsor.
-
Jun 20, 2024 |
ionanalytics.com | Bhavna Kaul |Cristiano Dalla Bona |Raj Saiya |Kevin Ketcham
Solenis, a Delaware-based producer of specialty chemicals used in water-intensive industries, has been engaging with investment banks as it considers going public in 2025, five sources familiar with the situation said. The company and its owner Platinum Equity have not formally launched a bake-off to firm up a syndicate of banks to help it with the IPO plans, the sources cautioned.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →